Fintel on MSN1d
Stephens & Co. Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Overweight RecommendationFintel reports that on November 18, 2024, Stephens & Co. initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback